Cancer resistance secrets revealed in massive genetic study
NCT ID NCT03347318
First seen Mar 19, 2026 · Last updated Jun 15, 2026 · Updated 9 times
Summary
This study aims to understand why some solid tumors stop responding to targeted therapies by analyzing their genetic profiles. Researchers will collect blood, saliva, and tumor samples from 2500 people with various cancers, including colorectal, breast, lung, and rare tumors. Some tumor samples will be grown in mice to study how genetic changes affect drug response. The goal is to improve future treatment decisions, not to test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O. Città della Salute e della Scienza di Torino - Presidio ospedaliero Ostetrico Ginecologico Sant'Anna
Turin, Italy
-
AOU Città della Salute e della Scienza di Torino - Presidio Molinette
Turin, Italy
-
AOU S. Luigi Gonzaga
Orbassano, Italy
-
Azienda Ospedaliera Niguarda Ca'Granda
Milan, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
-
Azienda Ospedaliero-Universitaria Careggi
Genova, Italy
-
Fondazione IRCCS - Istituto Nazionale dei Tumori
Milan, Italy
-
IEO - Istiuto Europeo di Oncologia
Milan, Italy
-
IOV - Istituto Oncologico Veneto
Padova, Italy
-
Istituto Di Candiolo - Fondazione Del Piemonte Per L'Oncologia (FPO-Irccs)
Candiolo, Italy
-
Ospedale Mauriziano Umberto I
Turin, Italy
-
Ospedale Regionale Umberto Parini
Aosta, Italy
-
Policlinico S.Orsola Malpighi
Bologna, Italy
-
Policlinico Universitario Campus Biomedico
Roma, Italy
-
Presidio Ospedaliero Martini
Turin, Italy
Conditions
Explore the condition pages connected to this study.